Treating Donors With Intravenous Immunoglobulin to Reduce Donor-Derived Infections
Status:
Not yet recruiting
Trial end date:
2024-09-01
Target enrollment:
Participant gender:
Summary
The goal of this clinical trial is to learn about the benefit of IVIG in donor-derived
infections and the potential immunomodulatory effect on transplanted organs. The main
questions it aims to answer are:
1. How effective IVIG is in preventing donor-derived infections
2. Does IVIG has potential immunomodulatory effect on transplanted organs